Concepedia

Mike Karmilowicz

MK

Statistics

Publications

3

Citations

170

H-Index

3

Active since

2013

Affiliations

Pfizer (United States)(Current)

Pfizer (Ireland)

University of Graz

Mike Karmilowicz is an author at Pfizer (United States) specializing in biocatalysis, catalytic mechanisms, and enzymatic catalysis.

Publications per year

2013–2014

3

Publications

3

Chemoenzymatic Asymmetric Synthesis of Pregabalin Precursors via Asymmetric Bioreduction of β-Cyanoacrylate Esters Using Ene-Reductases

Christoph K. Winkler, Dorina Clay, Simon B. Davies et al. · The Journal of Organic Chemistry · 2013 · 91 citations · Full text

, , +17

Evaluation of Several Routes to Advanced Pregabalin Intermediates: Synthesis and Enantioselective Enzymatic Reduction Using Ene-Reductases

Sébastien Debarge, Paul McDaid, P.M. O'Neill et al. · Organic Process Research & Development · 2013 · 45 citations

, , +13

Nitrile as Activating Group in the Asymmetric Bioreduction of β‐Cyanoacrylic Acids Catalyzed by Ene‐Reductases

Christoph K. Winkler, Dorina Clay, Nikolaus G. Turrini et al. · Advanced Synthesis & Catalysis · 2014 · 34 citations · Full text

, , +9

1–3 of 3